point of care

The company will use the funds to enhance the development of its AI capabilities and for commercial growth.  

Leveraging evidence-based knowledge in a meaningful way can help clinicians at the bedside during situations such as COVID-19, says Dr. Ian Chuang, chief medical officer for Elsevier's EMEALAAP Health business.